Zomepirac

Zomepirac

SCHEMBL8048305

Cc1c2c(n(C)c1C(=O)c1ccc(Cl)cc1)CCO2.Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.69
ABCB11 O95342 1/20 0.69
TDP1 Q9NUW8 3/20 0.54
CYP1A2 P05177 2/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PTGS1 P23219 3/20 0.35
CXCL8 P10145 1/20 0.35
AKR1B1 P15121 1/20 0.35
GLO1 Q04760 1/20 0.35
HPGD P15428 2/20 0.34
ABCB1 P08183 3/20 0.33
AKR1C3 P42330 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674449 0.85 ABCB11 (0.42) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL11495798 0.83 PTGS2 (1.00) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL25735 0.83 PTGS2 (1.00) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL43061 0.82 PTGS2 (0.97) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL9655800 0.82 PTGS2 (0.97) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL28350948 0.82 PTGS2 (0.97) PTGS2ABCB11TDP1CYP1A2ALDH1A1
Zomepirac SCHEMBL7204056 0.81 PTGS2 (0.95) PTGS2ABCB11TDP1CYP1A2ALDH1A1
SCHEMBL8050588 0.76 PTGS2 (0.55) PTGS2ABCB11TDP1CYP1A2ALDH1A1
SCHEMBL10905829 0.74 PTGS2 (0.80) PTGS2ABCB11TDP1CYP1A2ALDH1A1
SCHEMBL12608966 0.74 PTGS2 (0.80) PTGS2ABCB11TDP1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6160003-A 1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia CELL PATHWAYS, INC. (US) 2000-12-12 US disclosed